Minutes of the 12th Meeting of the Pharmaceutical and Medical Device Safety Measures Division, Safety Measures Subcommittee, FY2025

Key News Points

At the 12th Meeting of the Pharmaceutical and Medical Device Safety Measures Division, Safety Measures Subcommittee in FY2025, third-party succession as an alternative to closure or business dissolution was suggested as a response to succession issues. The importance of early preparation in 5-10 year increments starting around age 60 for chairpersons and directors was emphasized, and the utilization of specialized advisors for the medical industry was also recommended. This can be seen as indicating a concrete direction for ensuring the sustainability of medical institutions.

M&A Medical Editorial Department’s Perspective

The discussions at this Pharmaceutical and Medical Device Safety Measures Division meeting are noteworthy for clearly indicating that the administrative perspective on medical institution business succession issues is not limited to the option of mere “closure or dissolution.” In particular, the message urging early consideration of “third-party succession” over a 5-10 year span starting around age 60 will be a strong encouragement for many medical institution managers in concretely envisioning their institution’s future. M&A Medical (CentralMedience Inc.) has supported the formation of numerous third-party succession schemes that contribute to the maintenance and development of regional healthcare, and the discussions at this subcommittee suggest that such initiatives may accelerate further. For medical institutions facing a lack of successors, concrete paths to avoid closure and continue contributing to the local community are beginning to be shown even in public forums. This can be said to indicate that concrete paths for medical institutions facing a lack of successors to avoid closure and continue contributing to the local community are beginning to be shown even in public forums.

Points Raised by This News

• “Third-party succession” as an alternative to closure or dissolution was mentioned as an option in a public forum.
• The necessity of preparing for business succession in 5-10 year increments starting around age 60 for chairpersons and directors was suggested.
• The utilization of advisors specializing in the medical industry was recommended as an effective measure for smooth succession.
• The importance of third-party succession was reaffirmed in ensuring the continuity of regional healthcare.

Practical Questions Arising from This News

• What specific third-party succession schemes can be considered?
• What are the benefits of starting preparations around age 60?
• What kind of support can advisors specializing in the medical industry provide?

If You Feel “Should I Consult Too?”

If your institution’s chairperson or director is approaching age 60 and feels anxious about the lack of a successor or future management, the discussions at this subcommittee may be a sign that “now is the time to act.” We strongly recommend consulting with specialists early about the possibilities of third-party succession, which can achieve smooth business succession while protecting regional healthcare, rather than closure or dissolution. M&A Medical (CentralMedience Inc.) will propose the optimal succession plan tailored to your institution’s situation.

M&A Medical (CentralMedience Inc.) is an M&A support institution certified by the Small and Medium Enterprise Agency, supporting the business succession of medical corporations, hospitals, and clinics on a complete success fee basis. Consultations are accepted with strict confidentiality. Free consultation here